With the widespread implementation of antiretroviral therapy in many countries, the HIV/AIDS epidemic has declined. However, little is known about the prevalence of adherence rate to Highly Active Antiretroviral Therapy (HAART) in patients with HIV infection in China. This is the first meta-analysis of cross-sectional studies of treatment adherence (≥ 95%) to HAART in Chinese patients. Both English (PubMed, PsycINFO, EMBASE, and Web of Science) and Chinese (WanFang, CNKI, and SinoMed) databases were systematically and independently searched by three investigators. Studies with adherence rate estimates of HAART were included. Adherence rate estimates of each eligible study were extracted and pooled using the random-effects model. A total of 40 studies conducted in China were eligible and analyzed. The mean rate of ≥ 95% adherence to HAART was 81.1% (95%CI: 75.1%-88.0%, I 2 = 97.3%) at one week, 80.9% (95%CI: 74.7%-85.9%, I 2 = 96.6%) at one month, and 68.3% (95%CI: 46.1%-84.4%, I 2 = 97.1%) at 3 months or longer. Subgroup analyses revealed that samples with no gender predominance, low education level, middle economic region, rural area, older age (42.3 years), and recent publication (2013 or later) were correlated to higher HAART adherence. The average rate of HAART adherence was relatively high in China, which indicates effective HIV/AIDS policy, prevention and control measures. However, the HAART adherence rate decreased over the study time period.
Introduction
In the past decades Human Immunodeficiency Virus (HIV) infection has been a major public health challenge contributing to high disease burden worldwide (Maartens, Celum, & Lewin, 2014) . In 2015, approximately 36.7 million people lived with HIV infection in the world, but only 17 million people had access to antiretroviral therapy (UNAIDS, 2016) . As a result of recent widespread implementation of antiretroviral therapy in many countries, the HIV/AIDS epidemic has declined (WHO, 2013) . The Joint United Nations Program on HIV/Acquired Immune Deficiency Syndrome (AIDS) reported that AIDS-related deaths have decreased substantially, and by 2030 the AIDS epidemic is expected to end (UNAIDS, 2016) . The use of antiretroviral medication is effective in preventing and treating HIV infection (WHO, 2013) . The introduction of Highly Active Antiretroviral Therapy (HAART) in the mid-1990s, which suppresses HIV viral load led to a marked reduction in morbidity and mortality (Bhaskaran et al., 2008) . Due to the rapid replication and mutation rate of HIV, a very high level of treatment adherence (>95%) is required to ensure treatment effectiveness (Bangsberg et al., 2000) . However, strict adherence to a precise HIV regimen is typically poor due to the side effects of antiretroviral therapy and its complicated administration schedule. It is important to achieve full adherence to avoid treatment failure, development of resistant strains and AIDS (Sabin et al., 2015; Sethi, Celentano, Gange, Moore, & Gallant, 2003) . HAART adherence is calculated using the following formula (Ministry of Health, 2012) : adherence = Number of doses of HAART taken Number of prescribed doses of HAART × 100%
In mainland China (China thereafter) approximately 501,000 persons lived with HIV and AIDS in 2014 (National Health and Family Planning Commission, 2015) . Since 2002, the Chinese government has implemented the National Free Antiretroviral Treatment Program (NFATP), which covered approximately 97% of patients with HIV infection . The increasing trend of HIV drug resistance in China suggests suboptimal adherence to HARRT Sabin et al., 2015) . Examination of HAART treatment adherence in China could provide data that help improve HIV interventions. A meta-analysis involving 20 countries (Ortego et al., 2011) found that the average rate of HAART adherence (≥90%) was 62%, which is much lower than the recommended rate (>95%) (Bangsberg et al., 2000) . , 2015). However, the 2011 meta-analysis did not include papers from China. Therefore, we aimed to conduct the first meta-analysis of pooled HAART in Chinese patients with HIV infection.
Methods

Search strategy and selection criteria
English (PubMed, PsycINFO, EMBASE and Web of Science) and Chinese (WanFang, CNKI and SinoMed) databases were searched independently by three Investigators (YYW, YJ, and CC) from their inception until 24 October 2016. The following search terms were used: ("HAART" OR "highly active antiretroviral therapy" OR "ART" OR "antiretroviral therapy") AND ("adherence" OR "compliance") AND ("HIV" OR "AIDS" OR "human immunodeficiency virus" OR "acquired immune deficiency syndrome") AND ("Chinese" OR "China"). There was no restriction on sample size and study period. Reference lists of eligible studies and relevant review articles were hand-searched. First or corresponding authors were contacted for further information if necessary.
Studies that met the following inclusion criteria were included in the meta-analysis: (1) applied a clear definition and measurement of adherence to HAART with timeframe (e.g., 1 week, or 1 month); (2) reported HAART adherence level (e.g., ≥ 95%, 100%) or provided information to estimate the adherence; (3) had meta-analyzable cross-sectional data; and (4) were conducted in patients in China. Case series, reviews, meta-analyses and studies that did not provide definition or time-frame for adherence or adherence measurements, or HAART treatment (e.g., Chinese traditional medicine) were excluded.
Outcome measures
The primary outcome measure in this study was the proportion of patients who reported adherence of ≥ 95%. According to the Chinese NFATP guidelines, 95% of the adherence was the minimum requirement to achieve effectiveness for HAART (Ministry of Health, 2012). Hence, reported HAART adherence rate of ≥ 95% was the cut-off to define adherence rate.
Data extraction
Three independent investigators (YYW, YJ and CC) systematically undertook the search, assessed eligibility and extracted data. Any inconsistencies in the process were checked and resolved by involving a fourth reviewer (SBW). The following information was extracted: age, gender, education, occupation, province, rural or urban area, year of publication, survey time, study site, cutoffs of HAART adherence, time-frame (time from HAART initiation), definition and measurement of adherence, sampling method, sample size and response rate.
Assessment of study quality
For each study, two independent investigators (CC and YJ) conducted the methodological assessment and the critical appraisal for epidemiological studies (Loney, Chambers, Bennett, Roberts, & Stratford, 1998 ) that contains 8 items yielding a total score of 8: covering sampling, measurement and analysis. A total score of 7-8 was classified as high quality, 4-6 as moderate quality, and 0-3 as low quality (Loney et al., 1998) . Any inconsistencies were solved through discussion with a third investigator (YYW).
Data synthesis and statistical analyses
The Comprehensive Meta-Analysis software, Version 2.0 (http://www.meta-analysis.com/) was administered to synthesize data using the random effects model (DerSimonian & Laird, 1986) in all the meta-analytic outcomes. Heterogeneity of meta-analytic outcomes was measured using I 2 with I 2 values greater than 50% indicating heterogeneity of significance (Higgins, Thompson, Deeks, & Altman, 2003) . Publication bias was assessed using the funnel plots and Egger's test (Egger, Davey Smith, Schneider, & Minder, 1997) . All analyses were 2 tailed, with alpha set at 0.05.
In order to approximate homogeneity of meta-analytic results, the data were collapsed into 4 groups according to the time-frame of treatment adherence: (1) < 1-week adherence, (2) 1-week adherence, (3) 1month adherence, and (4) ≥ 3-month adherence. In each group, adherence to HAART was further divided according to two cut-offs (≥ 95% and/or 100%).
Eight subgroup analyses were conducted for 1 week and 1 month adherence separately according to the following factors: (a) level of adherence: 100% vs. ≥ 95%; (b) gender: male predominance (male percentage ≥ 60%) vs. no-predominance; (c) education: equal to and above junior high school vs. below junior high school (6 years education); (d) occupation: predominance of farmers vs. no such predominance; (e) economic region: West vs. Middle vs. East of China; (f) area: rural vs. urban vs. urban and rural; (g) age: 42.3 years old, using the median splitting method; (h) year of publication: year 2013, using the median splitting method.
Results
Literature search
After duplications were removed, a total of 965 potentially relevant articles in the initial database search were identified and scrutinized. Finally, 40 studies that fulfilled the study entry criteria were included in the meta-analysis ( Figure 1 ).
Studies, participants and treatment characteristics
The characteristics of the selected studies in the metaanalysis are listed in Table 1 . A total of 11,615 participants taking HAART in 40 studies conducted between 2005 and 2016 were included. The sample size in the studies ranged from 25 to 1,244. The HAART adherence time-frame ranged from 3 days to 18 months.
Most study arms used ≥ 95% and/or 100% as the adherence rates. There were 19 study arms in the 1 week adherence group, with one study arm (Chen, 2014) having the HAART adherence level of ≥ 90% not included in the analysis. There were 22 study arms in the 1 month adherence group, with one study (Morisky, Green, & Levine, 1986) using the Morisky medication adherence scale (≥ 15 points) (He, Jiang, & Li, 2014) and another using adherence level of ≥ 90% (Lin, Sun, Wang, & Fu, 2010) that were not included in the synthesis. There were 5 study arms (Chen et al., 2016; Song et al., 2006; Tian et al., 2006; Xu et al., 2010; Zhou et al., 2007) in the ≥ 3 months adherence group, 4 study arms in the < 1 week adherence group (Wang & Wu, 2007; Yan et al., 2012; Yu et al., 2012; Zhao, 2010) ; all these arms applied ≥ 95% or ≥ 100% as cut-offs.
Altogether 47 arms in 40 studies were included in the meta-analysis: 18 arms in 18 studies were in the 1 week adherence group, 20 arms in 18 studies in the 1 month adherence group, 5 arms in 5 studies in the ≥ 3 months adherence group, and 4 arms in 4 studies in the < 1 week adherence group.
Three studies reported both 1-week and 1-month adherence (Tian, 2013; Xiao et al., 2014; Yao et al., 2015) , therefore the two timeframes in each study were analyzed separately. Similarly, two studies (Chen et al., 2016; Tian et al., 2006) reported both 1-week and ≥ 3-month adherence, thus the two timeframes in each study were also analyzed separately. Two studies (Tian, 2012; Xiao et al., 2014) reported both ≥ 95% and 100% cutoffs in separate arms and were analyzed separately.
Primary outcomes
1-week Adherence
Adherence data were available in 14 arms with 100% adherence to HAART, and in 4 arms with ≥ 95% adherence. Adherence was assessed with the Morisky total score in four studies (Cheng et al., 2012; Li et al., 2014; Liang et al., 2012; Xue et al., 2013) , and the rest calculated the number of HAART pills taken divided by number of HAART pills prescribed in the past week.
The weighted mean effect size of patients with ≥ 95% adherence to HAART in 1 week was 81.1% (95%CI: 75.1%-88.0%, I 2 = 97.3%, Supplemental Figure 1 ). The results of the subgroup analyses are shown in Table 2 . Compared to the non-male predominance group, male predominance group showed lower HAART adherence rate. Compared to patients with below junior high school education, patients with junior high school or above education showed lower adherence rate. The middle economic region had the highest adherence rate, followed by the east and west economic regions. Patients recruited in rural area had the highest adherence rate, followed by mixed urban and rural areas, and urban area. Using 42.3 years of age as the median split value, patients with a mean age below 42.3 years showed lower adherence rate. Using publication year of 2013 as median split value, articles published before 2013 tended to report lower adherence rate.
1-month Adherence
Data on treatment adherence were available in 9 arms with 100% adherence to HAART, and in 11 arms with ≥ 95% adherence. Adherence was calculated as the number of HAART pills taken divided by the number of HAART pills prescribed over the past month.
The weighted mean effect size of patients with ≥ 95% adherence HAART at 1 month was 80.9% (95%CI: 74.7%-85.9%, I 2 = 96.6%, Supplemental Figure 2 ). The results of the 1-month subgroup analyses were shown in Table 3 . Non-male predominance, below junior high school education, middle economic region and rural area, older age (equal and above 42.3 years old), and recently published articles (in and after 2013) tended to report higher HAART adherence.
≥ 3-month adherence and < 1-week adherence
The weighted mean effect size of patients with ≥ 95% adherence to HAART ≥ 3 months was 68.3% (95%CI: 46.1%-84.4%, I 2 = 97.181%, Supplemental Figure 3) . The weighted mean effect size of patients with ≥ 95% adherence to HAART less than 1 week was 76.8% (95%CI: 54.3%-90.2%, I 2 = 93.9%, Supplemental Figure 4 ). Due to the small number of studies, subgroup analyses were not conducted. 
Publication bias
No publication bias was observed according to the results of visual funnel plot (Supplemental Figures 5 and 6 ) and the Egger's tests (p = 0.819 for 1 week, p = 0.329 for 1 month).
Discussion
This was the first meta-analysis that gave a comprehensive overview of HAART adherence in China. The rate of HAART adherence decreased over the study time period. The mean HAART adherence of ≥ 95% was 81.1% in 1 week, 80.9% in one month, and 68.3%≥ in 3 months.
A meta-analysis found that the average rate of ≥ 90% treatment adherence was 62% across 20 countries (Ortego et al., 2011) . HAART treatment adherence varies greatly across countries (Burkhart & Sabate, 2003; Pinheiro, de-Carvalho-Leite, Drachler, & Silveira, 2002; Weiser et al., 2003) . However, due to substantial heterogeneity in HIV/AIDS treatment schedules it is uncertain whether results of studies from different countries can be meaningfully synthesized. This study found the HAART adherence rate was relatively high in China, which could indicate the effectiveness of Chinese governmental protocol on HAART. China's NFATP has been implemented for more than a decade and has made significant progress by offering free HAART nationwide Zhang et al., 2009 ). In addition, education programs on HIV/AIDS have been conducted in both urban and rural areas (Liu et al., 2010) . All these factors may have contributed to the high HAART adherence found in this meta-analysis.
In the subgroup analyses the male predominance sample had lower adherence rate. Treatment adherence usually requires sustained attention (Bijker et al., 2017) ; compared to women, men often forget or do not comply with medical advice due to a variety of social and psychological factors (Bijker et al., 2017) . Health professionals need to adopt effective measures to improve men's treatment adherence to HAART. Recent studies reported higher adherence rate, which could be due to the consolidation of HIV/AIDS control measures in the context of the Chinese government's HIV/AIDS policy initiatives. Higher level of adherence was associated with older age, which is consistent with previous findings (Goujard et al., 2003) . The association between older age and higher treatment adherence will need future studies to identify the reasons and the direction of causality.
Socioeconomic status is closely associated with HIV control. This study found that patients with a lower education level, living in the middle economic region or rural area had higher HAART adherence. In rural areas and the middle economic region in China, such as Henan province, HIV/AID infection rate has been higher than in the rest of the country. In recent years, to improve adherence to HAART in in rural and low economic areas, the Chinese government has made it a priority to enhance adherence monitoring and access to health care in rural areas (Wang & Wu, 2007; Zhang et al., 2008) . The finding of low education level being associated with increased HAART adherence was also consistent with the finding of a French study (Goujard et al., 2003) . Traditionally, Chinese people with lower education, particularly in rural areas, have higher regard for health professionals, and thus they are more likely to comply with the HAART adherence guidelines.
This study has several limitations. First, substantial heterogeneity remained in subgroup analysis as it is the case in meta-analysis of epidemiological studies Long et al., 2014; Winsper et al., 2013) . Second, HAART adherence was measured by self-report questionnaires, which is not as accurate as objective measurements, such as electronic devices and blood level of the medication. Third, due to the cross-sectional design of the included studies, the causal relationship between HAART adherence and other variables could not be explored. Finally, the HAART adherence timeframe beyond 18 months could not be examined.
Conclusions
The results of this meta-analysis showed that HAART adherence rate in China is relatively high. However, the HAART adherence rate decreased over the study time period. Considering the importance of high treatment adherence, it will be necessary to examine the factors related to long-term adherence in future studies.
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